Literature DB >> 21028946

Primary cutaneous cryptococcosis caused by Cryptococcus gattii in an immunocompetent host.

Carlos Alberto Leão1, Kennio Ferreira-Paim, Leonardo Andrade-Silva, Delio Jose Mora, Paulo Roberto da Silva, Anna Silva Machado, Priscila Freitas Das Neves, Giovana Silva Pena, Luciana Silva de Almeida Teixeira, Mario León Silva-Vergara.   

Abstract

This paper presents the case of a 75-year-old Brazilian man who developed inflammatory skin lesions with nodules and ulcerations on the right forearm after an injury caused by handling barbed-wire and Eucalyptus spp. logs. Histopathological assessment of the lesions showed granulomatous processes with yeasts similar to Cryptococcus spp. Tissue fragments yielded yeasts when cultured that were identified as Cryptococcus gattii VGII through biochemical reactions and URA5-RFLP genotype. No evidence of systemic involvement or any underlying immunosuppressive diseases were identified, which supported the diagnosis of primary cutaneous cryptococcosis. After 5 months on therapy with high fluconazole doses, the skin lesions had fully healed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21028946     DOI: 10.3109/13693786.2010.530697

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  9 in total

Review 1.  Conidiobolomycosis, cryptococcosis, and aspergillosis in sheep and goats: a review.

Authors:  Priscila Maria Silva do Carmo; Francisco A Uzal; Pedro M O Pedroso; Franklin Riet-Correa
Journal:  J Vet Diagn Invest       Date:  2020-09-14       Impact factor: 1.279

2.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

Review 3.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 4.  Systemic Review of Published Reports on Primary Cutaneous Cryptococcosis in Immunocompetent Patients.

Authors:  Lin Du; Yali Yang; Julin Gu; Jianghan Chen; Wanqing Liao; Yuanjie Zhu
Journal:  Mycopathologia       Date:  2015-03-04       Impact factor: 2.574

Review 5.  Fatal primary cutaneous cryptococcosis: case report and review of published literature.

Authors:  Y Liu; H Qunpeng; X Shutian; X Honglang
Journal:  Ir J Med Sci       Date:  2015-08-06       Impact factor: 1.568

6.  Primary cutaneous cryptococcosis treated with debridement and fluconazole monotherapy in an immunosuppressed patient: a case report and review of the literature.

Authors:  Jennifer Wang; Luther Bartelt; Deborah Yu; Anjali Joshi; Bradley Weinbaum; Tiffany Pierson; Michael Patrizio; Cirle A Warren; Molly A Hughes; Gerald Donowitz
Journal:  Case Rep Infect Dis       Date:  2015-02-02

7.  Disseminated cryptococcosis with cutaneous involvement in an immunocompetent patient.

Authors:  Gabriely Lessa Sacht; Alexandre Moretti de Lima; Yuri Chiarelli Perdomo; Rafaela Suguimoto Boigues; Luiz Carlos Takita; Günter Hans
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

8.  Disseminated cryptococcosis manifested as a single tumor in an immunocompetent patient, similar to the cutaneous primary forms.

Authors:  Danielle Mechereffe do Amaral; Ritha de Cássia Capelato Rocha; Luiz Euribel Prestes Carneiro; Dewton Moraes Vasconcelos; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

9.  Rim Pathway-Mediated Alterations in the Fungal Cell Wall Influence Immune Recognition and Inflammation.

Authors:  Kyla S Ost; Shannon K Esher; Chrissy M Leopold Wager; Louise Walker; Jeanette Wagener; Carol Munro; Floyd L Wormley; J Andrew Alspaugh
Journal:  mBio       Date:  2017-01-31       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.